Serendipity Partners

Serendipity Partners

Risikokapital og forvaltning for aktiv eierkapital

We accelerate growth in Nordic healthcare companies

Om oss

Serendipity Partners is a strategic, hands-on investor and partner that brings deep sector expertise to Nordic healthcare companies

Nettsted
https://serpar.no/
Bransje
Risikokapital og forvaltning for aktiv eierkapital
Bedriftsstørrelse
2–10 ansatte
Hovedkontor
Oslo
Type
Ansvarlig bedrift

Beliggenheter

Ansatte i Serendipity Partners

Oppdateringer

  • 🚀Another great company joins the Medu Group platform! We are thrilled to partner with Johannes Skjervheim and the rest of the team. Welcome to the Medu family!🎉

    Vis organisasjonssiden til Medu Group, grafisk

    292 følgere

    A warm welcome to Skjervheimgruppen – the latest member of the Medu family! With this acquisition, Medu enters a new market.   Skjervheimgruppen is a company with an outstanding footprint in the Norwegian market of infant health centers (helsestasjoner). Since 2009 they have been preferred partner to their customers, helping them support and safekeep newborns and their parents, during the magic first days, months and years of a new life.   – For Medu, Skjervheimgruppen is a perfect portfolio fit; they are quality and customer focused, have a strong market position and reputation, and they truly understand and support their customers and their «patients», says Torkild Stenbock, Medu CEO. With Johannes Skjervheim and Skjervheimgruppen on board, Medu Norge expands their portfolio and market, with yet more high quality products.   – As a small niche company we are excited to join Medu and become part of something bigger. I believe the advantages for us are many, especially within realizing existing and new potential opportunities, says Johannes Skjervheim, general manager and founder of Skjervheimgruppen. 

    • Ingen alternativ tekstbeskrivelse for dette bildet
  • We're strengthening the Serendipity Partners team!🚀 With 15+ years of experience as a healthcare entrepreneur, executive and advisor across Europe and the US together with a strong educational background as an MD, PhD from Karolinska Institute, Andreas Ringman Uggla brings a wealth of relevant experience. We're confident that Andreas will bring new perspectives to our team and we look forward to the exciting journey ahead🚀

    Time for my next adventure - as General Partner at Serendipity Partners! It is time for me to leave the “24 family” after having built first Doktor24, one of the leading digital care providers in Sweden, and thereafter Platform24, which we expanded across 5 countries into a market-leading SaaS healthtech provider. What a journey it has been and I will forever be grateful to all of the amazing people who made our success possible. 🙏 You know who you are! So, I was asking myself - what do you do after having worked in so many different corners of healthcare across multiple countries? I knew I was looking for a small and entrepreneurial setup where I could give back and share everything I have learned so far. All of the successes and also all of the failures. I wanted to work with “my crowd” - people with a background in healthcare who are truly, deeply passionate about our part of the universe. I found all of that and more in the team at Serendipity Partners. Brilliant, yet humble individuals who are focusing on only one thing - becoming the very best at investing in and supporting innovative healthcare companies to develop and grow. I will join the team as a General Partner heading up the Stockholm office as of April 1st. Please reach out to me if you want to talk Venture & Growth stage healthcare companies, because that is what we do. The only thing we do actually and we are pretty darn good at it. Let’s talk! 🙌 #healthcare #privateequity #venturecapital #healthtech #saas Tobias Perdahl Jacob Stedman Daniel Lillienau Daniel Kernell Dr. med. Carol Wildhagen Marijn Meuwese Jonathan Ilicki Aleksandra Dennier Lars Mariero Michael Bodd Synne H. Røine Vanja Ericson-Engvall Albert Örwall

    • Ingen alternativ tekstbeskrivelse for dette bildet
  • Serendipity Partners la ut dette på nytt

    📢 We are thrilled to welcome another great company to our portfolio whose vision is: Saving limbs, lives, and reducing human suffering!🎉      With over 40 years of deep expertise in fiber optics, lasers, camera optics, and tissue optics, Perimed AB is a world leader in advanced instruments for diagnostics of peripheral vascular disease.   We are excited for the next step in the journey and to partner with Bjorn Bakken, Lena Åredal and the rest of the team in Perimed AB🎉

    Vis organisasjonssiden til Perimed AB, grafisk

    1 564 følgere

    Today, we are announcing our collaboration with Serendipity Partners, which has acquired 49% of Perimed AB. This strategic investment and capital influx will help us boost our expansion in the US while we continue to innovate, grow, and deliver instruments for the assessment of a globally soaring patient population. Serendipity is an ideal investment partner for us, as we are both rooted in healthcare and share a deep passion for solutions that deliver positive outcomes for patients and society. You can read more about our new partners and our owner’s thoughts in the press release: https://lnkd.in/dE6GiSet #Perimed #SerendipityPartners

    • Ingen alternativ tekstbeskrivelse for dette bildet
  • 📢 We are thrilled to welcome another great company to our portfolio whose vision is: Saving limbs, lives, and reducing human suffering!🎉      With over 40 years of deep expertise in fiber optics, lasers, camera optics, and tissue optics, Perimed AB is a world leader in advanced instruments for diagnostics of peripheral vascular disease.   We are excited for the next step in the journey and to partner with Bjorn Bakken, Lena Åredal and the rest of the team in Perimed AB🎉

    Vis organisasjonssiden til Perimed AB, grafisk

    1 564 følgere

    Today, we are announcing our collaboration with Serendipity Partners, which has acquired 49% of Perimed AB. This strategic investment and capital influx will help us boost our expansion in the US while we continue to innovate, grow, and deliver instruments for the assessment of a globally soaring patient population. Serendipity is an ideal investment partner for us, as we are both rooted in healthcare and share a deep passion for solutions that deliver positive outcomes for patients and society. You can read more about our new partners and our owner’s thoughts in the press release: https://lnkd.in/dE6GiSet #Perimed #SerendipityPartners

    • Ingen alternativ tekstbeskrivelse for dette bildet
  • 💥MEDU MILESTONE!💥 We are thrilled to welcome another great company to the Medu Group platform! We extend a warm welcome to Conworx Service GmbH and Dieter Kern, who are now part of the Medu family!🎉

Tilsvarende sider

Finansiering

Serendipity Partners 1 av runde

Siste runde

Serie ukjent
Se mer informasjon på Crunchbase